Patents Assigned to Omnio AB
  • Publication number: 20180280329
    Abstract: The present invention relates to methods and compositions used to reduce or prevent organ, tissue and cellular damage induced by irradiation exposure, such as radiodermatitis and radio mucositis. The compositions according to the invention comprise one or more inhibitors of plasminogen or one or more inhibitors of a component of the plasminogen activating pathway.
    Type: Application
    Filed: September 22, 2016
    Publication date: October 4, 2018
    Applicant: OMNIO AB
    Inventors: Tor NY, Mahsa FALLAH, Malgorzata WILCZYNSKA, Michael BLOMQUIST, Mikael JOHANSSON
  • Publication number: 20070041962
    Abstract: The present invention relates to the use of plasminogen and plasmin as agents for enhancing healing of tympanic membrane perforations or other wounds, and for reducing scars or necrotic tissue forming during wound healing. The invention also relates to a method for screening of compounds which enhance wound healing by evaluating the healing of tympanic membrane perforations in an animal model.
    Type: Application
    Filed: October 18, 2005
    Publication date: February 22, 2007
    Applicant: Omnio AB
    Inventors: Tor Ny, Jinan Li, Sten Hellstrom, Per-Olof Eriksson
  • Patent number: 7067492
    Abstract: The present invention relates to the use of plasminogen and plasmin as agents for enhancing healing of tympanic membrane perforations or other wounds, and for reducing scars or necrotic tissue forming during wound healing. The invention also relates to a method for screening of compounds which enhance wound healing by evaluating the healing of tympanic membrane perforations in an animal model.
    Type: Grant
    Filed: September 5, 2002
    Date of Patent: June 27, 2006
    Assignee: Omnio AB
    Inventors: Tor Ny, Jinan Li, Sten Hellstrom, Per-Olof Eriksson
  • Publication number: 20030147879
    Abstract: The present invention relates to the use of plasminogen and plasmin as agents for enhancing healing of tympanic membrane perforations or other wounds, and for reducing scars or necrotic tissue forming during wound healing. The invention also relates to a method for screening of compounds which enhance wound healing by evaluating the healing of tympanic membrane perforations in an animal model.
    Type: Application
    Filed: September 5, 2002
    Publication date: August 7, 2003
    Applicant: OMNIO AB
    Inventors: Tor Ny, Jinan Li, Sten Hellstrom, Per-Olof Eriksson
  • Publication number: 20030096733
    Abstract: Novel drug targets for the treatment or prevention of arthritis are provided. Screening methods for inhibitors of the plasminogen-activation pathway, such as, for example, antagonists or inhibitors of the urokinase-type plasminogen activator (uPA), plasminogen-activator type 1 (PAI-1), the urokinase activator receptor (uPAR), and plasmin, are used to identify novel drugs for treating or preventing the progression of arthritis. Such screening methods, or methods for evaluating whether a drug is useful for treating or preventing arthritis, can also be conducted in animal models described herein. Methods of treating or preventing such diseases are also provided.
    Type: Application
    Filed: July 10, 2002
    Publication date: May 22, 2003
    Applicant: Omnio AB
    Inventors: Tor Ny, Rikard Holmdahl, Jinan Li